Drug intelligence / Profile preview

BH Testosterone Booster

Development stage: Unknown
Lead developer: Aytu BioPharma
Modality: Small Molecules
Administration: Oral

Overview

BH Testosterone Booster is an over-the-counter natural health product developed by Innovus Pharmaceuticals. It is formulated as oral capsules containing botanical extracts, specifically clinical doses of *Eurycoma longifolia* (Tongkat Ali) and Fenugreek. The product is designed to support natural testosterone production, libido, energy, and stamina in adult males. Its primary mechanism involves eurycomanone, a constituent of Tongkat Ali, which acts as an aromatase inhibitor to prevent the conversion of testosterone into estrogen, thereby maintaining higher levels of free testosterone. It received a Natural Health Product License (NPN 80090740) from Health Canada in 2019.

Brand names: BH Testosterone Booster

Targets

CYP19A1 (Aromatase)

Beyond the preview

Go deeper on BH Testosterone Booster.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BH Testosterone Booster.

Explore the full profile